Cleveland Biolabs (CBLI) Reports Q2 Loss of $0.50/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/15/2026
- Nasdaq ends sharply lower as hot inflation data stirs rate-hike worries
- Oil prices gain on attacks in Saudi Arabia, Iran's new tactics to target tankers
- U.S. consumer prices rise by 3.7% year-on-year in September
- Bank of America stock falls on earnings miss
- Netflix cuts 1,000 jobs as streaming giant seeks to boost engagement
Tweet
Share
E-mailGet Alerts CBLI Hot Sheet
Price: $3.17 --0%
Financial Fact:
LOSS ATTRIBUTABLE TO NONCONTROLLING INTERESTS: -2.14K
Today's EPS Names:
FMCB, BANF, LOOP, More
Financial Fact:
LOSS ATTRIBUTABLE TO NONCONTROLLING INTERESTS: -2.14K
Today's EPS Names:
FMCB, BANF, LOOP, More
Join SI Premium – FREE
Cleveland Biolabs (NASDAQ: CBLI) reported Q2 EPS of ($0.50), versus ($0.17) reported last year.
For earnings history and earnings-related data on Cleveland Biolabs (CBLI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi Names Top Electrical Equipment Stocks Ahead of Earnings Season
- Mizuho Upgrades Array Technologies (ARRY) to Outperform
- Microsoft (MSFT) PT Raised to $625 at TD Cowen
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
